247 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Zinnige Zorg room for improvement report - Appropriate post-treatment surveillance of women treated for breast cancer

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 25-07-2016

Fingolimod (Gilenya®)

Zorginstituut Nederland has advised on amending the conditional inclusion of the medicine fingolimod (Gilenya®) in the Medicines ...

Report | 08-07-2016

Future scenarios about drug development and drug pricing

This report is the result of a consultative and deliberative process — initiated by the Belgian Healthcare Knowledge Centre (KCE) ...

Report | 28-06-2016

Guideline for economic evaluations in healthcare

This new Guideline unifies all previously available Dutch guidelines, links up with international developments, provides un ...

Guideline | 16-06-2016

Tranylcypromine (Tracydal®) in patients with a severe multi-resistant depressive disorder

Zorginstituut Nederland carried out a budget impact analysis for the medicine tranylcypromine (Tracydal®). They reached the ...

Report | 15-06-2016

Tolperison (Tolpermyo®)

Zorginstituut Nederland has drawn up a pharmacotherapeutic report for the medicine tolperison (Tolpermyo®), whereby it reached ...

Report | 25-05-2016

Brivaracetam (Briviact®)

Zorginstituut Nederland has approved a pharmacotherapeutic report for the medicine brivaracetam (Briviact®), whereby they reached ...

Report | 23-05-2016

Lumacaftor/ivacaftor (Orkambi®) by Cystic fibrosis

Based on the GVS criteria, lumacaftor/ivacaftor (Orkambi®) can not be replaced by another drug in the GVS.  The assessment ...

Report | 13-05-2016

Eculizumab (Soliris®) for the treatment of patients with paroxysmal nocturnal haemogloninuria

Zorginstituut Nederland has re-assessed the medicine eculizumab (Soliris®) for the treatment of patients with paroxysmal ...

Report | 13-05-2016

Levo floxacin (Quinsair®) for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa

Zorginstituut Nederland carried out a marginal assessment of the medicine levofloxacin (Quinsair®), whereby they came to the ...

Report | 03-05-2016